Scientists studied the Mediterranean shrub L. (), which is rich in bioactive compounds. It has antibacterial, anti-inflammatory, and antioxidant properties. Of particular interest is its potential in treating type 2 diabetes. Its multifaceted benefits make it a promising candidate for drug development.
Researchers identified 27 Ecuadorian plants traditionally used for diabetes treatment with bioactive compounds. Promising antidiabetic potential, but more research needed for integration into modern medicine and economic benefit.
Researchers synthesized strontium nanoparticles from , a plant with antidiabetic and anticancer properties. These nanoparticles showed potential in treating diabetes and cancer, making them a promising therapeutic strategy.
Study investigated therapeutic potential of plant extract for cancer, diabetes, and wound healing. Extract showed promising anticancer, antidiabetic, and wound healing activities. Contains key bioactive compounds. Could lead to new herbal treatments.
Researchers identified catechin in fruit as a potential antidiabetic compound through molecular docking. Catechin shows promise for drug development and could offer a more cost-effective solution for managing diabetes.
Researchers studied the plant Smilax china L. (Jingangteng) and its use in treating gynecological inflammation. They found that Jingangteng capsules may regulate glucose and lipid metabolism, providing potential health benefits.
Study showed that polysaccharides from three Huanglian plants improved T2DM in mice by balancing gut microbiota, increasing SCFAs, and affecting metabolic pathways. Gut health is crucial for managing T2DM.
Researchers studied the antidiabetic effects of leaves in diabetic rats. Results suggest potential for treating diabetes. Important for developing new therapies for diabetes.